Preclinical Study Identifies GALE as Checkpoint Restricting Vγ9Vδ2 T Cell Killing
A genome-wide CRISPR screen identified the metabolic enzyme GALE as a tumor-intrinsic checkpoint that limits Vγ9Vδ2 T cell-mediated tumor killing ...
A genome-wide CRISPR screen identified the metabolic enzyme GALE as a tumor-intrinsic checkpoint that limits Vγ9Vδ2 T cell-mediated tumor killing ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.